1-6 of 6
Scott Marshall
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Molecular MRD is strongly prognostic in patients with NPM1 -mutated AML receiving venetoclax-based nonintensive therapy

Clinical Trials & Observations Brief Report
Jad Othman, Ing S. Tiong, Jenny O'Nions, Mike Dennis, Katya Mokretar, Adam Ivey, Michael Austin, Anne-Louise Latif, Mariam Amer, Wei Yee Chan, Charles Crawley, Francesca Crolla, Joe Cross, Ray Dang, Johnathon Elliot, Chun Y. Fong, Sofia Galli, Paolo Gallipoli, Francesca Hogan, Pallavi Kalkur, Anjum Khan, Pramila Krishnamurthy, John Laurie, Sun Loo, Scott Marshall, Priyanka Mehta, Vidhya Murthy, Sateesh Nagumantry, Srinivas Pillai, Nicola Potter, Rob Sellar, Tom Taylor, Rui Zhao, Nigel H. Russell, Andrew H. Wei, Richard Dillon
Journal: Blood
Blood (2024) 143 (4): 336–341.
https://doi.org/10.1182/blood.2023021579
Published: 2024
Includes: Supplemental data
Journal Articles

Cryoglobulinemia Is More Frequently Associated with IgM Paraproteins Than Previously Reported, Interfering with Their Quantification, and Resulting in Potential Treatment Delays

Aaron Laurence Niblock, Philip Logue, Philip Windrum, Joanne Murdock, Scott Marshall McCloskey, Bridgin Merron, Suzanne McPherson, Elinor Hanna, Terence Robert Lappin, Treen C. Morris
Journal: Blood
Blood (2022) 140 (Supplement 1): 11966–11967.
https://doi.org/10.1182/blood-2022-170321
Published: 2022
Journal Articles

Rapid Infusion with CT-P10 in Patients with Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukaemia: Interim Six Month Follow-up from a European Non-Interventional Post-Authorisation Safety Study

Mark Bishton, Pier Luigi Zinzani, MD PhD, Scott Marshall, Veronica Conteh, Alicia Rodríguez Fernández, SooKyoung Kim, Young Nam Lee
Journal: Blood
Blood (2019) 134 (Supplement_1): 4135.
https://doi.org/10.1182/blood-2019-121957
Published: 2019
Journal Articles

Results Of The Randomised Phase II NCRI Arctic (Attenuated dose Rituximab with ChemoTherapy In CLL) Trial Of Low Dose Rituximab In Previously Untreated CLL

Peter Hillmen, MB ChB, PhD, Donald Milligan, MD, FRCP, FRCPath, Anna Schuh, MD, PhD, Lucy McParland, Anna Chalmers, Tahla Munir, MB ChB, Abraham M Varghese, MB ChB, Andy C Rawstron, BSc, PhD, David J Allsup, MD, PhD, Scott Marshall, MD, Alex Smith, BSc, Corinne Collett, Walter Gregory, PhD, Andrew Duncombe, MD, Dena Cohen, BSc, MSc
Journal: Blood
Blood (2013) 122 (21): 1639.
https://doi.org/10.1182/blood.V122.21.1639.1639
Published: 2013
Journal Articles

P B S-1086, a “Pan-Rel” Inhibitor, Decreases Viability of Chronic Lymphocytic Leukemia Cells

Susan J Tudhope, BSc, PhD, Evan A Mulligan, BSc, PhD, Jill E Hunter, BSc, PhD, Geoffrey P Summerfield, MD, Scott Marshall, MD, Jonathan Wallis, MD, Helen Marr, Paul Evans, Chris Lowe, Barbara W Durkacz, BSc, PhD, Jie Zhang, PhD, Jeffrey Meshulam, BS, Kathryn Bobb, MS, Elaine Willmore, BSc, PhD
Journal: Blood
Blood (2012) 120 (21): 867.
https://doi.org/10.1182/blood.V120.21.867.867
Published: 2012
Journal Articles

Young Adults Aged 18 to 30 Years with Hodgkin Lymphoma Can Tolerate a Modified Version of the Combined Modality German Paediatric HD95 Protocol with Minimal Neurotoxicity and Excellent Outcome. Results of the UK NCRN 18–30 Study (CRUK/08/012)

Kirit M Ardeshna, MD, Peter Hoskin, Paul Smith, PhD, Nicholas Chadwick, Nivette Braganca, Wai-Lup Wong, MD, Irfan Kayani, Bal Sanghera, Patricia Diez, Helen Lucraft, Andrew Jack, PhD, MB, Christopher J McNamara, George Mikhaeel, MD, Scott Marshall, MD, Ruth Pettengell, Robert E. Marcus, MBBS, FRCP, FRCPath, Anton Kruger, David C Linch, MD FMedSci
Journal: Blood
Blood (2012) 120 (21): 1621.
https://doi.org/10.1182/blood.V120.21.1621.1621
Published: 2012